Monthly Archives: October 2013

Stivarga Approved for Canadian GIST Patients

Health Canada has expanded approval for the use of Stivarga to fight Gastrointestinal Stromal Tumours (GIST), according to an article from CNW. Bayer announced that Stivarga will now be available for treatment of adult patients with [...]

By |2019-09-20T11:39:34-04:00October 18th, 2013|Drug Treatment, News, Stivarga|

ARIAD Ponatinib Trial Pauses Accepting New Patients

ARIAD has announced that their ponatinib (Iclusig) trial, which some GIST patients are participating in, has paused new enrollment based on consultations with the FDA regarding patients who experienced particular vascular events. Subject to agreement with [...]

By |2019-09-20T11:44:57-04:00October 10th, 2013|Clinical Trials, News|
Go to Top